| Views | |
|---|---|
| Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | 81 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | 2 | 5 | 4 | 4 | 1 | 2 | 9 |
| Views | |
|---|---|
| Alkhawaldeh_Evaluation_23.pdf | 31 |
| Views | |
|---|---|
| United States | 19 |
| Canada | 14 |
| Germany | 4 |
| India | 4 |
| Japan | 2 |
| Vietnam | 2 |
| Australia | 1 |
| Russia | 1 |
| Views | |
|---|---|
| Ottawa | 14 |
| Durham | 4 |
| Mumbai | 4 |
| Mountain View | 3 |
| Sacramento | 2 |
| Baltimore | 1 |
| Dallas | 1 |
| Dearborn | 1 |
| Kanda | 1 |
| Mytishchi | 1 |